Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2026-02-26 @ 11:03 AM
Study NCT ID:
NCT02881567
Status:
TERMINATED
Last Update Posted:
2019-09-27
First Post:
2016-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab
Sponsor:
Biogen
Organization: